Sienna+® magnetic tracer is safe and has a long shelf life, allowing it to be used universally – not just near centers that have access to nuclear medicine. Since clinicians can perform the injections of Sienna+®, it helps to optimize the workflow and scheduling of SLNB.
The Sienna+® device is a dark brown fluid that contains a solution of tiny, coated iron oxide particles, each a few tens of nanometers in diameter. Particles of this size are easily absorbed into lymph capillaries and are ultimately trapped in lymph node sinuses for detection by the SentiMag®.
Sienna+® is CE approved for marketing and sales in Europe. Endomagnetics is currently seeking marketing authorization in other territories to deliver its technology to global markets.